© 2024 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations
TECHNOTE: 90.5 FM and AM870 reception

Competitor Permitted To Sell Lipitor Generic


NPR's business news starts with cheaper cholesterol drugs for many Americans.


INSKEEP: The drug maker Pfizer has lost the patent on its drug Lipitor. The patent expired in the United States yesterday. And on the same day, regulators granted an Indian company approval to sell a cheaper, generic version of the cholesterol drug in the U.S. market.

Pfizer has sold about $100 billion worth of Lipitor since 1997. Revenues are now expected to plummet. And more generic rivals are expected to hit the market soon, meaning consumers will be paying a fraction of the previous cost for that medication. Transcript provided by NPR, Copyright NPR.

To help strengthen our local reporting as WKAR's fiscal year ends, we need 75 new or upgraded sustainers by June 30th. Become a new monthly donor or increase your donation to support the trustworthy journalism you'll rely on before Election Day. Donate now.